Catalyst Pharmaceuticals Inc. is a biopharmaceutical company based in Coral Gables, Florida. The company is developing medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Firdapse commercially launched in January 2019. More information...
According to PR-model, catalystpharma.com is ranked 2,171,595th in multilingual Wikipedia, in particular this website is ranked 1,252,127th in English Wikipedia.
The website is placed before gnfpspatiala.org.in and after zgmx360.com in the BestRef global ranking of the most important sources of Wikipedia.
